Global Neurological Biomarkers Market Insights and Forecast to 2028

Report ID: 1542639 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Neurological Biomarkers Product Introduction
    1.2 Market by Type
        1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Proteomics
        1.2.3 Genomics
        1.2.4 Imaging
        1.2.5 Bioinformatics
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Diagnostics
        1.3.3 Drug Discovery
        1.3.4 Personalized Medicine
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Neurological Biomarkers Sales Estimates and Forecasts 2017-2028
    2.2 Global Neurological Biomarkers Revenue Estimates and Forecasts 2017-2028
    2.3 Global Neurological Biomarkers Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Neurological Biomarkers Sales by Region
        2.4.1 Global Neurological Biomarkers Sales by Region (2017-2022)
        2.4.2 Global Sales Neurological Biomarkers by Region (2023-2028)
    2.5 Global Neurological Biomarkers Revenue by Region
        2.5.1 Global Neurological Biomarkers Revenue by Region (2017-2022)
        2.5.2 Global Neurological Biomarkers Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Neurological Biomarkers Sales by Manufacturers
        3.1.1 Global Top Neurological Biomarkers Manufacturers by Sales (2017-2022)
        3.1.2 Global Neurological Biomarkers Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurological Biomarkers in 2021
    3.2 Global Neurological Biomarkers Revenue by Manufacturers
        3.2.1 Global Neurological Biomarkers Revenue by Manufacturers (2017-2022)
        3.2.2 Global Neurological Biomarkers Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Neurological Biomarkers Revenue in 2021
    3.3 Global Neurological Biomarkers Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Neurological Biomarkers Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Neurological Biomarkers Sales by Type
        4.1.1 Global Neurological Biomarkers Historical Sales by Type (2017-2022)
        4.1.2 Global Neurological Biomarkers Forecasted Sales by Type (2023-2028)
        4.1.3 Global Neurological Biomarkers Sales Market Share by Type (2017-2028)
    4.2 Global Neurological Biomarkers Revenue by Type
        4.2.1 Global Neurological Biomarkers Historical Revenue by Type (2017-2022)
        4.2.2 Global Neurological Biomarkers Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2017-2028)
    4.3 Global Neurological Biomarkers Price by Type
        4.3.1 Global Neurological Biomarkers Price by Type (2017-2022)
        4.3.2 Global Neurological Biomarkers Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Neurological Biomarkers Sales by Application
        5.1.1 Global Neurological Biomarkers Historical Sales by Application (2017-2022)
        5.1.2 Global Neurological Biomarkers Forecasted Sales by Application (2023-2028)
        5.1.3 Global Neurological Biomarkers Sales Market Share by Application (2017-2028)
    5.2 Global Neurological Biomarkers Revenue by Application
        5.2.1 Global Neurological Biomarkers Historical Revenue by Application (2017-2022)
        5.2.2 Global Neurological Biomarkers Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2017-2028)
    5.3 Global Neurological Biomarkers Price by Application
        5.3.1 Global Neurological Biomarkers Price by Application (2017-2022)
        5.3.2 Global Neurological Biomarkers Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Neurological Biomarkers Market Size by Type
        6.1.1 North America Neurological Biomarkers Sales by Type (2017-2028)
        6.1.2 North America Neurological Biomarkers Revenue by Type (2017-2028)
    6.2 North America Neurological Biomarkers Market Size by Application
        6.2.1 North America Neurological Biomarkers Sales by Application (2017-2028)
        6.2.2 North America Neurological Biomarkers Revenue by Application (2017-2028)
    6.3 North America Neurological Biomarkers Market Size by Country
        6.3.1 North America Neurological Biomarkers Sales by Country (2017-2028)
        6.3.2 North America Neurological Biomarkers Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Neurological Biomarkers Market Size by Type
        7.1.1 Europe Neurological Biomarkers Sales by Type (2017-2028)
        7.1.2 Europe Neurological Biomarkers Revenue by Type (2017-2028)
    7.2 Europe Neurological Biomarkers Market Size by Application
        7.2.1 Europe Neurological Biomarkers Sales by Application (2017-2028)
        7.2.2 Europe Neurological Biomarkers Revenue by Application (2017-2028)
    7.3 Europe Neurological Biomarkers Market Size by Country
        7.3.1 Europe Neurological Biomarkers Sales by Country (2017-2028)
        7.3.2 Europe Neurological Biomarkers Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Neurological Biomarkers Market Size by Type
        8.1.1 Asia Pacific Neurological Biomarkers Sales by Type (2017-2028)
        8.1.2 Asia Pacific Neurological Biomarkers Revenue by Type (2017-2028)
    8.2 Asia Pacific Neurological Biomarkers Market Size by Application
        8.2.1 Asia Pacific Neurological Biomarkers Sales by Application (2017-2028)
        8.2.2 Asia Pacific Neurological Biomarkers Revenue by Application (2017-2028)
    8.3 Asia Pacific Neurological Biomarkers Market Size by Region
        8.3.1 Asia Pacific Neurological Biomarkers Sales by Region (2017-2028)
        8.3.2 Asia Pacific Neurological Biomarkers Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Neurological Biomarkers Market Size by Type
        9.1.1 Latin America Neurological Biomarkers Sales by Type (2017-2028)
        9.1.2 Latin America Neurological Biomarkers Revenue by Type (2017-2028)
    9.2 Latin America Neurological Biomarkers Market Size by Application
        9.2.1 Latin America Neurological Biomarkers Sales by Application (2017-2028)
        9.2.2 Latin America Neurological Biomarkers Revenue by Application (2017-2028)
    9.3 Latin America Neurological Biomarkers Market Size by Country
        9.3.1 Latin America Neurological Biomarkers Sales by Country (2017-2028)
        9.3.2 Latin America Neurological Biomarkers Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Neurological Biomarkers Market Size by Type
        10.1.1 Middle East and Africa Neurological Biomarkers Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Neurological Biomarkers Revenue by Type (2017-2028)
    10.2 Middle East and Africa Neurological Biomarkers Market Size by Application
        10.2.1 Middle East and Africa Neurological Biomarkers Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Neurological Biomarkers Revenue by Application (2017-2028)
    10.3 Middle East and Africa Neurological Biomarkers Market Size by Country
        10.3.1 Middle East and Africa Neurological Biomarkers Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Corporation Information
        11.1.2 Thermo Fisher Scientific Overview
        11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Thermo Fisher Scientific Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 Quest Diagnostics
        11.3.1 Quest Diagnostics Corporation Information
        11.3.2 Quest Diagnostics Overview
        11.3.3 Quest Diagnostics Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Quest Diagnostics Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Quest Diagnostics Recent Developments
    11.4 Abbott
        11.4.1 Abbott Corporation Information
        11.4.2 Abbott Overview
        11.4.3 Abbott Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Abbott Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Abbott Recent Developments
    11.5 Roche
        11.5.1 Roche Corporation Information
        11.5.2 Roche Overview
        11.5.3 Roche Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Roche Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Roche Recent Developments
    11.6 Illumina
        11.6.1 Illumina Corporation Information
        11.6.2 Illumina Overview
        11.6.3 Illumina Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Illumina Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Illumina Recent Developments
    11.7 Bio-Rad Laboratories
        11.7.1 Bio-Rad Laboratories Corporation Information
        11.7.2 Bio-Rad Laboratories Overview
        11.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Bio-Rad Laboratories Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Bio-Rad Laboratories Recent Developments
    11.8 QIAGEN
        11.8.1 QIAGEN Corporation Information
        11.8.2 QIAGEN Overview
        11.8.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 QIAGEN Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 QIAGEN Recent Developments
    11.9 Myriad RBM
        11.9.1 Myriad RBM Corporation Information
        11.9.2 Myriad RBM Overview
        11.9.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Myriad RBM Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Myriad RBM Recent Developments
    11.10 Cisbio Bioassays
        11.10.1 Cisbio Bioassays Corporation Information
        11.10.2 Cisbio Bioassays Overview
        11.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Cisbio Bioassays Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Cisbio Bioassays Recent Developments
    11.11 Athena Diagnostics
        11.11.1 Athena Diagnostics Corporation Information
        11.11.2 Athena Diagnostics Overview
        11.11.3 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Athena Diagnostics Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Athena Diagnostics Recent Developments
    11.12 BGI
        11.12.1 BGI Corporation Information
        11.12.2 BGI Overview
        11.12.3 BGI Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 BGI Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 BGI Recent Developments
    11.13 Wuxi APP
        11.13.1 Wuxi APP Corporation Information
        11.13.2 Wuxi APP Overview
        11.13.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Wuxi APP Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Wuxi APP Recent Developments
    11.14 Aepodia
        11.14.1 Aepodia Corporation Information
        11.14.2 Aepodia Overview
        11.14.3 Aepodia Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Aepodia Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Aepodia Recent Developments
    11.15 Proteome Sciences
        11.15.1 Proteome Sciences Corporation Information
        11.15.2 Proteome Sciences Overview
        11.15.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Proteome Sciences Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Proteome Sciences Recent Developments
    11.16 Genewiz
        11.16.1 Genewiz Corporation Information
        11.16.2 Genewiz Overview
        11.16.3 Genewiz Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Genewiz Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Genewiz Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Neurological Biomarkers Industry Chain Analysis
    12.2 Neurological Biomarkers Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Neurological Biomarkers Production Mode & Process
    12.4 Neurological Biomarkers Sales and Marketing
        12.4.1 Neurological Biomarkers Sales Channels
        12.4.2 Neurological Biomarkers Distributors
    12.5 Neurological Biomarkers Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Neurological Biomarkers Industry Trends
    13.2 Neurological Biomarkers Market Drivers
    13.3 Neurological Biomarkers Market Challenges
    13.4 Neurological Biomarkers Market Restraints
14 Key Findings in The Global Neurological Biomarkers Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Neurological Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Proteomics
    Table 3. Major Manufacturers of Genomics
    Table 4. Major Manufacturers of Imaging
    Table 5. Major Manufacturers of Bioinformatics
    Table 6. Major Manufacturers of Others
    Table 7. Global Neurological Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Neurological Biomarkers Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Neurological Biomarkers Sales by Region (2017-2022) & (K Units)
    Table 10. Global Neurological Biomarkers Sales Market Share by Region (2017-2022)
    Table 11. Global Neurological Biomarkers Sales by Region (2023-2028) & (K Units)
    Table 12. Global Neurological Biomarkers Sales Market Share by Region (2023-2028)
    Table 13. Global Neurological Biomarkers Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Neurological Biomarkers Revenue Market Share by Region (2017-2022)
    Table 15. Global Neurological Biomarkers Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Neurological Biomarkers Revenue Market Share by Region (2023-2028)
    Table 17. Global Neurological Biomarkers Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Neurological Biomarkers Sales Share by Manufacturers (2017-2022)
    Table 19. Global Neurological Biomarkers Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Neurological Biomarkers Revenue Share by Manufacturers (2017-2022)
    Table 21. Neurological Biomarkers Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2021)
    Table 24. Neurological Biomarkers Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Neurological Biomarkers Product Offered
    Table 26. Date of Manufacturers Enter into Neurological Biomarkers Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 29. Global Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
    Table 30. Global Neurological Biomarkers Sales Share by Type (2017-2022)
    Table 31. Global Neurological Biomarkers Sales Share by Type (2023-2028)
    Table 32. Global Neurological Biomarkers Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Neurological Biomarkers Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Neurological Biomarkers Revenue Share by Type (2017-2022)
    Table 35. Global Neurological Biomarkers Revenue Share by Type (2023-2028)
    Table 36. Neurological Biomarkers Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Neurological Biomarkers Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 39. Global Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
    Table 40. Global Neurological Biomarkers Sales Share by Application (2017-2022)
    Table 41. Global Neurological Biomarkers Sales Share by Application (2023-2028)
    Table 42. Global Neurological Biomarkers Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Neurological Biomarkers Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Neurological Biomarkers Revenue Share by Application (2017-2022)
    Table 45. Global Neurological Biomarkers Revenue Share by Application (2023-2028)
    Table 46. Neurological Biomarkers Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Neurological Biomarkers Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 49. North America Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
    Table 50. North America Neurological Biomarkers Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Neurological Biomarkers Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 53. North America Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
    Table 54. North America Neurological Biomarkers Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Neurological Biomarkers Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Neurological Biomarkers Sales by Country (2017-2022) & (K Units)
    Table 57. North America Neurological Biomarkers Sales by Country (2023-2028) & (K Units)
    Table 58. North America Neurological Biomarkers Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Neurological Biomarkers Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Neurological Biomarkers Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Neurological Biomarkers Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Neurological Biomarkers Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Neurological Biomarkers Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Neurological Biomarkers Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Neurological Biomarkers Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Neurological Biomarkers Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Neurological Biomarkers Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Neurological Biomarkers Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Neurological Biomarkers Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Neurological Biomarkers Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Neurological Biomarkers Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Neurological Biomarkers Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Neurological Biomarkers Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Neurological Biomarkers Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Neurological Biomarkers Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Neurological Biomarkers Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Neurological Biomarkers Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Neurological Biomarkers Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Neurological Biomarkers Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Neurological Biomarkers Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Neurological Biomarkers Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Neurological Biomarkers Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Neurological Biomarkers Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Neurological Biomarkers Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Neurological Biomarkers Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Neurological Biomarkers Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Neurological Biomarkers Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Neurological Biomarkers Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Neurological Biomarkers Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Neurological Biomarkers Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Neurological Biomarkers Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Neurological Biomarkers Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Neurological Biomarkers Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Neurological Biomarkers Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Neurological Biomarkers Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Thermo Fisher Scientific Corporation Information
    Table 109. Thermo Fisher Scientific Description and Major Businesses
    Table 110. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Thermo Fisher Scientific Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Thermo Fisher Scientific Recent Developments
    Table 113. Merck Corporation Information
    Table 114. Merck Description and Major Businesses
    Table 115. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Merck Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Merck Recent Developments
    Table 118. Quest Diagnostics Corporation Information
    Table 119. Quest Diagnostics Description and Major Businesses
    Table 120. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Quest Diagnostics Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Quest Diagnostics Recent Developments
    Table 123. Abbott Corporation Information
    Table 124. Abbott Description and Major Businesses
    Table 125. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Abbott Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Abbott Recent Developments
    Table 128. Roche Corporation Information
    Table 129. Roche Description and Major Businesses
    Table 130. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Roche Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Roche Recent Developments
    Table 133. Illumina Corporation Information
    Table 134. Illumina Description and Major Businesses
    Table 135. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Illumina Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Illumina Recent Developments
    Table 138. Bio-Rad Laboratories Corporation Information
    Table 139. Bio-Rad Laboratories Description and Major Businesses
    Table 140. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Bio-Rad Laboratories Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Bio-Rad Laboratories Recent Developments
    Table 143. QIAGEN Corporation Information
    Table 144. QIAGEN Description and Major Businesses
    Table 145. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. QIAGEN Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. QIAGEN Recent Developments
    Table 148. Myriad RBM Corporation Information
    Table 149. Myriad RBM Description and Major Businesses
    Table 150. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Myriad RBM Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Myriad RBM Recent Developments
    Table 153. Cisbio Bioassays Corporation Information
    Table 154. Cisbio Bioassays Description and Major Businesses
    Table 155. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Cisbio Bioassays Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Cisbio Bioassays Recent Developments
    Table 158. Athena Diagnostics Corporation Information
    Table 159. Athena Diagnostics Description and Major Businesses
    Table 160. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. Athena Diagnostics Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Athena Diagnostics Recent Developments
    Table 163. BGI Corporation Information
    Table 164. BGI Description and Major Businesses
    Table 165. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 166. BGI Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. BGI Recent Developments
    Table 168. Wuxi APP Corporation Information
    Table 169. Wuxi APP Description and Major Businesses
    Table 170. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 171. Wuxi APP Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Wuxi APP Recent Developments
    Table 173. Aepodia Corporation Information
    Table 174. Aepodia Description and Major Businesses
    Table 175. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 176. Aepodia Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Aepodia Recent Developments
    Table 178. Proteome Sciences Corporation Information
    Table 179. Proteome Sciences Description and Major Businesses
    Table 180. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 181. Proteome Sciences Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Proteome Sciences Recent Developments
    Table 183. Genewiz Corporation Information
    Table 184. Genewiz Description and Major Businesses
    Table 185. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 186. Genewiz Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Genewiz Recent Developments
    Table 188. Key Raw Materials Lists
    Table 189. Raw Materials Key Suppliers Lists
    Table 190. Neurological Biomarkers Distributors List
    Table 191. Neurological Biomarkers Customers List
    Table 192. Neurological Biomarkers Market Trends
    Table 193. Neurological Biomarkers Market Drivers
    Table 194. Neurological Biomarkers Market Challenges
    Table 195. Neurological Biomarkers Market Restraints
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neurological Biomarkers Product Picture
    Figure 3. Global Neurological Biomarkers Market Share by Type in 2021 & 2028
    Figure 3. Proteomics Product Picture
    Figure 4. Genomics Product Picture
    Figure 5. Imaging Product Picture
    Figure 6. Bioinformatics Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Neurological Biomarkers Market Share by Application in 2021 & 2028
    Figure 9. Diagnostics
    Figure 10. Drug Discovery
    Figure 11. Personalized Medicine
    Figure 12. Others
    Figure 13. Neurological Biomarkers Report Years Considered
    Figure 14. Global Neurological Biomarkers Sales 2017-2028 (K Units)
    Figure 15. Global Neurological Biomarkers Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Neurological Biomarkers Revenue 2017-2028 (US$ Million)
    Figure 17. Global Neurological Biomarkers Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Neurological Biomarkers Sales Market Share by Region (2017-2022)
    Figure 19. Global Neurological Biomarkers Sales Market Share by Region (2023-2028)
    Figure 20. North America Neurological Biomarkers Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Neurological Biomarkers Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Neurological Biomarkers Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Neurological Biomarkers Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Neurological Biomarkers Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Neurological Biomarkers Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Neurological Biomarkers Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Neurological Biomarkers Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Neurological Biomarkers Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Neurological Biomarkers Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Neurological Biomarkers Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Neurological Biomarkers in the World: Market Share by Neurological Biomarkers Revenue in 2021
    Figure 32. Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Neurological Biomarkers Sales Market Share by Type (2017-2028)
    Figure 34. Global Neurological Biomarkers Revenue Market Share by Type (2017-2028)
    Figure 35. Global Neurological Biomarkers Sales Market Share by Application (2017-2028)
    Figure 36. Global Neurological Biomarkers Revenue Market Share by Application (2017-2028)
    Figure 37. North America Neurological Biomarkers Sales Market Share by Type (2017-2028)
    Figure 38. North America Neurological Biomarkers Revenue Market Share by Type (2017-2028)
    Figure 39. North America Neurological Biomarkers Sales Market Share by Application (2017-2028)
    Figure 40. North America Neurological Biomarkers Revenue Market Share by Application (2017-2028)
    Figure 41. North America Neurological Biomarkers Sales Share by Country (2017-2028)
    Figure 42. North America Neurological Biomarkers Revenue Share by Country (2017-2028)
    Figure 43. U.S. Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Neurological Biomarkers Sales Market Share by Type (2017-2028)
    Figure 46. Europe Neurological Biomarkers Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Neurological Biomarkers Sales Market Share by Application (2017-2028)
    Figure 48. Europe Neurological Biomarkers Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Neurological Biomarkers Sales Share by Country (2017-2028)
    Figure 50. Europe Neurological Biomarkers Revenue Share by Country (2017-2028)
    Figure 51. Germany Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 52. France Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Neurological Biomarkers Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Neurological Biomarkers Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Neurological Biomarkers Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Neurological Biomarkers Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Neurological Biomarkers Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Neurological Biomarkers Revenue Share by Region (2017-2028)
    Figure 62. China Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 65. India Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Neurological Biomarkers Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Neurological Biomarkers Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Neurological Biomarkers Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Neurological Biomarkers Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Neurological Biomarkers Sales Share by Country (2017-2028)
    Figure 77. Latin America Neurological Biomarkers Revenue Share by Country (2017-2028)
    Figure 78. Mexico Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Neurological Biomarkers Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Neurological Biomarkers Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Neurological Biomarkers Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Neurological Biomarkers Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Neurological Biomarkers Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Neurological Biomarkers Revenue Share by Country (2017-2028)
    Figure 87. Turkey Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Neurological Biomarkers Revenue (2017-2028) & (US$ Million)
    Figure 90. Neurological Biomarkers Value Chain
    Figure 91. Neurological Biomarkers Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Frequently Asked Questions
Neurological Biomarkers report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neurological Biomarkers report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neurological Biomarkers report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

N-Heptane

N-Heptane market is segmented by Type and by Application. Players, stakeholders, and other partic ... Read More

Shipping Containers

Shipping Containers market is segmented by players, region (country), by Type and by Application. ... Read More